Loading...

Major Indexes

Free Cash Flow

Cleveland BioLabs Inc.

Cleveland BioLabs Inc. (CBLI)

$2.17
-0.08 (-3.56%)

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 8.493.702.713.521.951.140.920.680.500.370.27
Revenue (%)
Operating Cash Flow -23.10-14.46-12.08-5.04-6.61-4.61-2.66-2.22-1.63-1.20-0.88
Operating Cash Flow (%)
Capital Expenditure -----------
Capital Expenditure (%)
Free Cash Flow -23.10-14.46-12.08-5.04-6.61-4.61-2.66-2.22-1.63-1.20-0.88

FCF Unlevered from cash flow statement